Establishment of a New Orthotopic Perirenal-Space-Grafted Mouse Model of Retroperitoneal Sarcoma
Fu'an Xie,Dongmei Qin,Lanlan Lian,Ming Li,Xu Kong,Xiaogang Xia,Liyong Huang,Jun Chen,Chundong Yu,C. Luo,Wengang Li
DOI: https://doi.org/10.21203/rs.3.rs-89811/v1
2020-01-01
Abstract:Background: Retroperitoneal sarcoma is a group of tumour originating from mesenchymal tissue in the retroperitoneal space. Although its incidence is lower than other tumours, retroperitoneal sarcoma has attracted increasing attention due to their high degree of malignancy, high recurrence rate and younger tendency. At present, the available treatments for retroperitoneal sarcoma are limited due to a lack of basic research and appropriate animal models. Results: In this study, two human sarcoma cell lines (dedifferentiated liposarcoma cell line SW872 and fibrosarcoma cell line HT1080) were selected to establish an orthotopic xenotransplantation retroperitoneal sarcoma mouse model. To achieve this, sarcoma cells labelled with GFP-Luc-Puro tag were inoculated into the perirenal space of nude mice. We evaluated the model by live imaging, histopathology and transcriptome analysis. Doxorubicin and Cisplatin were used to test the response of this model to chemotherapy drugs. The abdominal bulge of mice was obvious after 15 days for HT1080 and 30 days for SW872. Obvious chemical signals could be detected by an imaging system (IVIS Lumina Ⅱ), and a solid tumour was visible in the abdominal cavity of live mice by MRI in vivo. Solid tumours inoculated in the perirenal space were significantly larger than subcutaneous tumours. Moreover, solid tumours treated with doxorubicin and cisplatin were significantly smaller than those treated with PBS. Through transcriptome analysis, we found serval signal pathway associated with tumorigenesis including TNF and NF-κB signaling pathways. Notably, a significant increase in copy number of MDM2 and a significant reduction in TP53, consistent with a shift in the MDM2/TP53 axis, with the most decisive genomic event contributing to liposarcoma development.Conclusions: In summary, we successfully established an orthotopic xenotransplantation model of retroperitoneal sarcoma, which can be used to study the initiation and development of retroperitoneal sarcoma, drug screening, diagnostic methods and new surgical procedures.